• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HOUSTON EYE-PAK OPHTHALMIC DRAPE; DRAPE, PATIENT, OPHTHALMIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HOUSTON EYE-PAK OPHTHALMIC DRAPE; DRAPE, PATIENT, OPHTHALMIC Back to Search Results
Catalog Number 8065103120
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Pain (1994)
Event Date 01/21/2020
Event Type  Injury  
Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
 
Event Description
A patient reported the skin from the scalp and temple area was removed with the drape and she experienced episodes of sharp pain after undergoing a cataract extraction procedure on her left eye.The patient initially indicated she used cortisone cream and the issue resolved after ten days.Addition information from the patient was received.The patient indicated she applied a triple antibiotic ointment for weeks and the area healed completely with no scarring, no residual effects and no pain.No additional information is expected.This is one report of two for this patient.
 
Manufacturer Narrative
Additional information provided in h.6.And h.10.The customer did not retain the product lot information for this custom pak procedure pack, therefore the device history records traceable to the reported pack could not be reviewed.The customer reported "this is not a complaint against alcon." it was reported a drape removed skin from the patient's cheek.The drape reported originates from a supplier manufacturer.No sample has been returned for evaluation; therefore, the condition of the product could not be verified to suggest the root cause originated from the drape or operator error.When this type of issue occurs, a sample(or image) should be returned so that a root cause evaluation can be performed.The root cause of the customer's complaint could not be established as a sample has not been received and the condition of the product could not be verified.Without analysis of the sample, it is not possible to isolate the root cause.As the root cause is unknown, the relationship, if any, of the device to the reported incident cannot be determined.After an investigation of this complaint, it has been determined that no action will be taken at this time as a sample was not returned and a root cause evaluation could not be performed.All lots are verified that all required inspections have been performed and all acceptance criteria are met prior to release.The manufacturer internal reference number is: 2020-12742.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EYE-PAK OPHTHALMIC DRAPE
Type of Device
DRAPE, PATIENT, OPHTHALMIC
Manufacturer (Section D)
ALCON RESEARCH, LLC - HOUSTON
9965 buffalo speedway
houston TX 77054
MDR Report Key9848061
MDR Text Key183932628
Report Number1644019-2020-00151
Device Sequence Number1
Product Code HMT
Combination Product (y/n)N
PMA/PMN Number
K830822
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Remedial Action Other
Type of Report Initial,Followup
Report Date 06/15/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/18/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number8065103120
Device Lot NumberASKU
Was Device Available for Evaluation? No
Date Manufacturer Received05/26/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
NEOSPORIN OINTMENT; NEOSPORIN OINTMENT
Patient Outcome(s) Required Intervention;
-
-